全文获取类型
收费全文 | 6280篇 |
免费 | 377篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 79篇 |
儿科学 | 546篇 |
妇产科学 | 87篇 |
基础医学 | 648篇 |
口腔科学 | 85篇 |
临床医学 | 414篇 |
内科学 | 1358篇 |
皮肤病学 | 69篇 |
神经病学 | 389篇 |
特种医学 | 128篇 |
外科学 | 884篇 |
综合类 | 142篇 |
预防医学 | 334篇 |
眼科学 | 432篇 |
药学 | 667篇 |
中国医学 | 24篇 |
肿瘤学 | 376篇 |
出版年
2023年 | 33篇 |
2022年 | 38篇 |
2021年 | 180篇 |
2020年 | 129篇 |
2019年 | 154篇 |
2018年 | 205篇 |
2017年 | 123篇 |
2016年 | 150篇 |
2015年 | 192篇 |
2014年 | 266篇 |
2013年 | 315篇 |
2012年 | 418篇 |
2011年 | 409篇 |
2010年 | 253篇 |
2009年 | 207篇 |
2008年 | 358篇 |
2007年 | 340篇 |
2006年 | 309篇 |
2005年 | 298篇 |
2004年 | 274篇 |
2003年 | 230篇 |
2002年 | 184篇 |
2001年 | 135篇 |
2000年 | 142篇 |
1999年 | 109篇 |
1998年 | 33篇 |
1997年 | 31篇 |
1996年 | 20篇 |
1995年 | 20篇 |
1993年 | 32篇 |
1992年 | 72篇 |
1991年 | 67篇 |
1990年 | 70篇 |
1989年 | 63篇 |
1988年 | 70篇 |
1987年 | 59篇 |
1986年 | 59篇 |
1985年 | 63篇 |
1984年 | 50篇 |
1983年 | 41篇 |
1980年 | 37篇 |
1979年 | 37篇 |
1978年 | 30篇 |
1977年 | 30篇 |
1975年 | 37篇 |
1974年 | 38篇 |
1973年 | 24篇 |
1972年 | 25篇 |
1971年 | 26篇 |
1970年 | 31篇 |
排序方式: 共有6662条查询结果,搜索用时 15 毫秒
1.
2.
3.
Virendra N Sehgal Ananta Khurana Vibhu Mendiratta Deepti Saxena Govind Srivastava Ashok K Aggarwal 《Indian journal of dermatology》2015,60(4):327-331
Atopic dermatitis is a well-recognized clinical entity, several facets of which continue to be mystified. Accordingly, its etio-pathogenesis is largely elusive. It appears to be an outcome of interplay of several undertones, namely: genetics, maternal factor and inheritance, pregnancy/intrauterine, environmental factors, immune dysregulation, immuno-globulins, role of diet, and infection. Besides, recent innovative breakthroughs consisting of nutritional supplementation, the highlights of which were considered worthwhile to take stock of to define its current status. An endeavor to enlighten the audience has been made for their benefit. 相似文献
4.
5.
6.
7.
8.
Aditya Kelkar Caroll Webers Rohit Shetty Jai Kelkar Nikhil Labhsetwar Abhishek Pandit Madhulika Malode Sayali Tidke 《Indian journal of ophthalmology》2020,68(10):2143
Purpose:To evaluate the rate of compliance and the reasons for loss to follow-up in Indian patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) being treated with anti-vascular endothelial growth factor (VEGF) therapy.Methods:This was a retrospective single-center study. Patients with DME, AMD, or RVO were eligible if they initiated anti-VEGF therapy between January 2013 and December 2017. Patients'' data were obtained from hospital electronic records, including the number of injections received, visits, details of follow-up, missed appointments, and reasons for loss to follow-up (>365 days).Results:A total of 648 patients were eligible for the study, of which 334 (51.54%) patients were lost to follow-up. Overall, 343 (64.96%) were males and the overall mean (SD) age was 66.40 (7.44) years. A total of 376 (58.0%) patients had a history of diabetes and 364 (56.2%) patients had a history of hypertension. Further, 127 (38.0), 112 (33.5), and 95 (28.4) had DME, AMD, and RVO, respectively and were lost to follow-up. The most commonly reported reason for loss to follow-up was “non-affordability” (n = 120; 41.1%) followed by “no improvement in vision” (n = 83; 28.4%). “No improvement in vision” (42.2%) and “non-affordability” (37.5%) were higher among patients with DME. No association was found in gender- and treatment-wise distribution of reasons for loss to follow-up.Conclusion:The results showed that around half of the patients with DME, AMD, and RVO were lost to follow-up to intravitreal anti-VEGF therapy, and the most common factors were “non-affordability” and “no improvement in vision.” 相似文献
9.
10.